Natco Pharma launches generic drug for PAH in the U.S.
Natco Pharma has launched Bosentan tablets for oral suspension, 32mg, a generic version of Actelion Pharmaceuticals’ Tracleer in the U.S. It holds the first-to-file status for this product and will have 180-day generic drug exclusivity, Natco said on Wednesday (August 20, 2025. Lupin is its marketing partner for the product. Bosentan TFOS, 32mg, had estimated…
Read More “Natco Pharma launches generic drug for PAH in the U.S. ” »